344 related articles for article (PubMed ID: 31671902)
21. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
22. The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.
Karaki S; Andrieu C; Ziouziou H; Rocchi P
Adv Protein Chem Struct Biol; 2015; 101():1-26. PubMed ID: 26572974
[TBL] [Abstract][Full Text] [Related]
23. Translation initiation in cancer: a novel target for therapy.
Meric F; Hunt KK
Mol Cancer Ther; 2002 Sep; 1(11):971-9. PubMed ID: 12481419
[TBL] [Abstract][Full Text] [Related]
24. How strong is the case for regulation of the initiation step of translation by elements at the 3' end of eukaryotic mRNAs?
Kozak M
Gene; 2004 Dec; 343(1):41-54. PubMed ID: 15563830
[TBL] [Abstract][Full Text] [Related]
25. An RNA trapping mechanism in Alphavirus mRNA promotes ribosome stalling and translation initiation.
Toribio R; Díaz-López I; Boskovic J; Ventoso I
Nucleic Acids Res; 2016 May; 44(9):4368-80. PubMed ID: 26984530
[TBL] [Abstract][Full Text] [Related]
26. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
27. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA.
Weingarten-Gabbay S; Khan D; Liberman N; Yoffe Y; Bialik S; Das S; Oren M; Kimchi A
Oncogene; 2014 Jan; 33(5):611-8. PubMed ID: 23318444
[TBL] [Abstract][Full Text] [Related]
28. Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment.
Willis RE
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649156
[TBL] [Abstract][Full Text] [Related]
29. uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.
Chen HH; Tarn WY
RNA Biol; 2019 Oct; 16(10):1327-1338. PubMed ID: 31234713
[TBL] [Abstract][Full Text] [Related]
30. Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment.
Koromilas AE
Biochim Biophys Acta; 2015 Jul; 1849(7):871-80. PubMed ID: 25497381
[TBL] [Abstract][Full Text] [Related]
31. NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
[TBL] [Abstract][Full Text] [Related]
32. Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.
Digregorio M; Lombard A; Lumapat PN; Scholtes F; Rogister B; Coppieters N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795417
[TBL] [Abstract][Full Text] [Related]
33. Control of translation initiation in animals.
Gray NK; Wickens M
Annu Rev Cell Dev Biol; 1998; 14():399-458. PubMed ID: 9891789
[TBL] [Abstract][Full Text] [Related]
34. [Initiation factors eIF4: from sea urchin embryonic development to chronic lymphocytic leukemia].
Saad H; Bellé R; Morales J; Cosson B; Mulner-Lorillon O; Berthou C; Cormier P
J Soc Biol; 2007; 201(3):307-15. PubMed ID: 18157083
[TBL] [Abstract][Full Text] [Related]
35. Identifying small molecule inhibitors of eukaryotic translation initiation.
Cencic R; Robert F; Pelletier J
Methods Enzymol; 2007; 431():269-302. PubMed ID: 17923239
[TBL] [Abstract][Full Text] [Related]
36. mTOR, translation initiation and cancer.
Mamane Y; Petroulakis E; LeBacquer O; Sonenberg N
Oncogene; 2006 Oct; 25(48):6416-22. PubMed ID: 17041626
[TBL] [Abstract][Full Text] [Related]
37. The cancer stem cell hypothesis: a guide to potential molecular targets.
Allegra A; Alonci A; Penna G; Innao V; Gerace D; Rotondo F; Musolino C
Cancer Invest; 2014 Nov; 32(9):470-95. PubMed ID: 25254602
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of ribosomal subunit joining during eukaryotic translation initiation.
Acker MG; Lorsch JR
Biochem Soc Trans; 2008 Aug; 36(Pt 4):653-7. PubMed ID: 18631135
[TBL] [Abstract][Full Text] [Related]
39. Human Cytomegalovirus Strategies to Maintain and Promote mRNA Translation.
Vincent HA; Ziehr B; Moorman NJ
Viruses; 2016 Apr; 8(4):97. PubMed ID: 27089357
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic translation initiation factors and cancer.
Ali MU; Ur Rahman MS; Jia Z; Jiang C
Tumour Biol; 2017 Jun; 39(6):1010428317709805. PubMed ID: 28653885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
